NewGenIvf Group Statistics
Total Valuation
NewGenIvf Group has a market cap or net worth of $1.71 million. The enterprise value is -$1.07 million.
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NewGenIvf Group has 9.89 million shares outstanding.
| Current Share Class | 9.82M |
| Shares Outstanding | 9.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.48% |
| Owned by Institutions (%) | 0.03% |
| Float | 9.78M |
Valuation Ratios
The trailing PE ratio is 1.52 and the forward PE ratio is 0.00.
| PE Ratio | 1.52 |
| Forward PE | 0.00 |
| PS Ratio | 0.37 |
| Forward PS | n/a |
| PB Ratio | 0.06 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.06.
| Current Ratio | 1.06 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -10.69 |
Financial Efficiency
Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is -48.11%.
| Return on Equity (ROE) | 5.51% |
| Return on Assets (ROA) | -26.91% |
| Return on Invested Capital (ROIC) | -48.11% |
| Return on Capital Employed (ROCE) | -42.55% |
| Weighted Average Cost of Capital (WACC) | 26.97% |
| Revenue Per Employee | $53,238 |
| Profits Per Employee | $12,864 |
| Employee Count | 87 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 15.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -100.00% in the last 52 weeks. The beta is 0.17, so NewGenIvf Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -100.00% |
| 50-Day Moving Average | 8.12 |
| 200-Day Moving Average | 294.12 |
| Relative Strength Index (RSI) | 20.73 |
| Average Volume (20 Days) | 1,481,247 |
Short Selling Information
The latest short interest is 125,342, so 1.27% of the outstanding shares have been sold short.
| Short Interest | 125,342 |
| Short Previous Month | 2.47M |
| Short % of Shares Out | 1.27% |
| Short % of Float | 1.28% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, NewGenIvf Group had revenue of $4.63 million and earned $1.12 million in profits.
| Revenue | 4.63M |
| Gross Profit | 1.11M |
| Operating Income | -11.03M |
| Pretax Income | 951,299 |
| Net Income | 1.12M |
| EBITDA | -10.69M |
| EBIT | -11.03M |
| Earnings Per Share (EPS) | n/a |
Full Income Statement Balance Sheet
The company has $4.43 million in cash and $1.65 million in debt, with a net cash position of $2.78 million or $0.28 per share.
| Cash & Cash Equivalents | 4.43M |
| Total Debt | 1.65M |
| Net Cash | 2.78M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 25.71M |
| Book Value Per Share | 733.75 |
| Working Capital | 618,325 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$14.64 million and capital expenditures -$181,842, giving a free cash flow of -$14.82 million.
| Operating Cash Flow | -14.64M |
| Capital Expenditures | -181,842 |
| Depreciation & Amortization | 343,169 |
| Net Borrowing | 7.53M |
| Free Cash Flow | -14.82M |
| FCF Per Share | -$1.50 |
Full Cash Flow Statement Margins
Gross margin is 23.89%, with operating and profit margins of -238.22% and 24.16%.
| Gross Margin | 23.89% |
| Operating Margin | -238.22% |
| Pretax Margin | 20.54% |
| Profit Margin | 24.16% |
| EBITDA Margin | -230.81% |
| EBIT Margin | -238.22% |
| FCF Margin | n/a |
Dividends & Yields
NewGenIvf Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 65.76% |
| FCF Yield | -870.85% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 285.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 23, 2026. It was a reverse split with a ratio of 1:8.
| Last Split Date | Oct 23, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
NewGenIvf Group has an Altman Z-Score of -0.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.71 |
| Piotroski F-Score | 1 |